Sensus Healthcare, Inc. (SRTS) stock
SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3041% below fair value
$2.26−0.08 (-3.42%)
Close on Nov 17, 2026Market cap $37.20MP/E –Yield –
Sensus Healthcare revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Sensus Healthcare's revenue for the twelve months ending Sep 30, 2026 was $16.62M, down 53.3% year over year. For fiscal 2025 it was $27.48M, down 34.3% from the year before. Over ten years it grew 10.3% a year on average. The highest annual figure on record is $44.53M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.48M | -34.3% |
| FY2024 | Dec 31, 2024 | $41.81M | +71.3% |
| FY2023 | Dec 31, 2023 | $24.41M | -45.2% |
| FY2022 | Dec 31, 2022 | $44.53M | +64.7% |
| FY2021 | Dec 31, 2021 | $27.04M | +182.4% |
| FY2020 | Dec 31, 2020 | $9.58M | -64.9% |
| FY2019 | Dec 31, 2019 | $27.26M | +3.2% |
| FY2018 | Dec 31, 2018 | $26.43M | +28.4% |
| FY2017 | Dec 31, 2017 | $20.59M | +39.0% |
| FY2016 | Dec 31, 2016 | $14.81M | +44.2% |
| FY2015 | Dec 31, 2015 | $10.27M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.00M | -12.9% |
| Q2 FY2026 | Jun 30, 2026 | $2.29M | -68.7% |
| Q1 FY2026 | Mar 31, 2026 | $3.39M | -59.3% |
| Q4 FY2025 | Dec 31, 2025 | $4.94M | -62.2% |
| Q3 FY2025 | Sep 30, 2025 | $6.88M | -22.1% |
| Q2 FY2025 | Jun 30, 2025 | $7.32M | -20.8% |
| Q1 FY2025 | Mar 31, 2025 | $8.34M | -21.7% |
| Q4 FY2024 | Dec 31, 2024 | $13.07M | +4.0% |
| Q3 FY2024 | Sep 30, 2024 | $8.84M | +126.8% |
| Q2 FY2024 | Jun 30, 2024 | $9.24M | +104.1% |
| Q1 FY2024 | Mar 31, 2024 | $10.66M | +212.3% |
| Q4 FY2023 | Dec 31, 2023 | $12.57M | -4.1% |
| Q3 FY2023 | Sep 30, 2023 | $3.90M | -56.7% |
| Q2 FY2023 | Jun 30, 2023 | $4.53M | -62.5% |
| Q1 FY2023 | Mar 31, 2023 | $3.41M | -67.0% |
| Q4 FY2022 | Dec 31, 2022 | $13.10M | +0.6% |
| Q3 FY2022 | Sep 30, 2022 | $9.01M | +63.1% |
| Q2 FY2022 | Jun 30, 2022 | $12.08M | +122.8% |
| Q1 FY2022 | Mar 31, 2022 | $10.34M | +236.7% |
| Q4 FY2021 | Dec 31, 2021 | $13.03M | +155.7% |
| Q3 FY2021 | Sep 30, 2021 | $5.53M | +241.0% |
| Q2 FY2021 | Jun 30, 2021 | $5.42M | +358.3% |
| Q1 FY2021 | Mar 31, 2021 | $3.07M | +82.8% |
| Q4 FY2020 | Dec 31, 2020 | $5.09M | -40.1% |
| Q3 FY2020 | Sep 30, 2020 | $1.62M | -72.3% |
| Q2 FY2020 | Jun 30, 2020 | $1.18M | -84.2% |
| Q1 FY2020 | Mar 31, 2020 | $1.68M | -69.1% |
| Q4 FY2019 | Dec 31, 2019 | $8.51M | +5.3% |
| Q3 FY2019 | Sep 30, 2019 | $5.84M | -7.8% |
| Q2 FY2019 | Jun 30, 2019 | $7.48M | +23.4% |
| Q1 FY2019 | Mar 31, 2019 | $5.44M | -8.7% |
| Q4 FY2018 | Dec 31, 2018 | $8.08M | +24.9% |
| Q3 FY2018 | Sep 30, 2018 | $6.33M | +32.1% |
| Q2 FY2018 | Jun 30, 2018 | $6.06M | +21.9% |
| Q1 FY2018 | Mar 31, 2018 | $5.96M | +36.8% |
| Q4 FY2017 | Dec 31, 2017 | $6.47M | +32.7% |
| Q3 FY2017 | Sep 30, 2017 | $4.80M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.97M | – |
| Q1 FY2017 | Mar 31, 2017 | $4.35M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.88M | – |
See a number that looks wrong?